← brief for 2026-11-02 · Slowing decline

cRGD engineered MSC-derived small extracellular vesicles as targeted delivery vehicles of miR-373 for liver fibrosis therapy

Article D Peer reviewed Preclinical

Key takeaways

This study tested a new way to treat liver scarring using tiny bubbles from stem cells. It was in cells, not people yet.

Who did this work

Mengjie Cai (Jiangsu University) · Fang Cheng (Jiangsu University) · Yu Zhang (Jiangsu University) · Jing Zhou (Jiangsu University) · Yongmin Yan (Jiangsu University) · Dawei Cui (First Affiliated Hospital Zhejiang University) · Yanan Wang (Jiangsu University) · Ying Chu (Jiangsu University) · Yanjin Wang (Jiangsu University)

Source

Article · OpenAlex, CKD works · 2026-10-31
https://doi.org/10.1186/s10020-026-01677-0